Helmholtz Association of German Research Centres

Diabetes

Diabetes: A duo helps better

Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone. Scientists from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, ...

Oncology & Cancer

Enhanced treatment of brain tumors

Glioblastoma is regarded as the most malignant form of brain tumor. In many cases, neurosurgeons are not able to remove such tumors completely because of the risk of destroying too much brain tissue in the process. Moreover, ...

Diabetes

Type 1 diabetes: Vitamin D deficiency occurs in an early stage

Vitamin D is known as a major regulator of calcium levels and bone metabolism. Furthermore, it also influences the immune system. Previous studies have shown that patients with recently diagnosed type 1 diabetes have significantly ...

Neuroscience

Misplaced molecules: New insights into the causes of dementia

A team of German and Belgian researchers has succeeded in gaining new insights into the causes of certain movement disorders and forms of dementia. Scientists including Bettina Schmid and Christian Haass from the German Center ...

Diabetes

Study explains why diabetic retinopathy is difficult to treat

Damage to the retina due to diabetes can be ameliorated only partially, despite treatment with the standard drug metformin. Scientists of Helmholtz Zentrum München have discovered that metformin treatment normalizes the ...

page 6 from 40